vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and IDEX Corporation (IEX). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($398.4M vs $329.5M, roughly 1.2× Andersons, Inc.). IDEX Corporation runs the higher net margin — 30.1% vs 20.5%, a 9.7% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (16.7% vs -2.4%). IDEX Corporation produced more free cash flow last quarter ($86.0M vs $-77.1M). Over the past eight quarters, Andersons, Inc.'s revenue compounded faster (-1.8% CAGR vs -29.4%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
ANDE vs IEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $398.4M |
| Net Profit | $67.4M | $120.0M |
| Gross Margin | 70.3% | 99.9% |
| Operating Margin | 26.6% | 43.3% |
| Net Margin | 20.5% | 30.1% |
| Revenue YoY | -2.4% | 16.7% |
| Net Profit YoY | 49.6% | 25.7% |
| EPS (diluted) | — | $1.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $398.4M | ||
| Q1 26 | — | $407.7M | ||
| Q4 25 | $329.5M | $899.1M | ||
| Q3 25 | $295.8M | $878.7M | ||
| Q2 25 | $535.0M | $865.4M | ||
| Q1 25 | $370.8M | $814.3M | ||
| Q4 24 | $337.5M | $862.9M | ||
| Q3 24 | $231.9M | $798.2M |
| Q2 26 | — | $120.0M | ||
| Q1 26 | — | $128.3M | ||
| Q4 25 | $67.4M | $128.3M | ||
| Q3 25 | $20.1M | $127.8M | ||
| Q2 25 | $7.9M | $131.6M | ||
| Q1 25 | $284.0K | $95.5M | ||
| Q4 24 | $45.1M | $123.2M | ||
| Q3 24 | $27.4M | $119.1M |
| Q2 26 | — | 99.9% | ||
| Q1 26 | — | 94.9% | ||
| Q4 25 | 70.3% | 43.1% | ||
| Q3 25 | 57.8% | 44.5% | ||
| Q2 25 | 29.6% | 45.3% | ||
| Q1 25 | 41.2% | 45.3% | ||
| Q4 24 | 63.1% | 42.5% | ||
| Q3 24 | 76.4% | 44.3% |
| Q2 26 | — | 43.3% | ||
| Q1 26 | — | 45.0% | ||
| Q4 25 | 26.6% | 20.4% | ||
| Q3 25 | 8.7% | 21.1% | ||
| Q2 25 | 4.6% | 21.7% | ||
| Q1 25 | 0.9% | 17.4% | ||
| Q4 24 | 19.9% | 19.2% | ||
| Q3 24 | 26.8% | 21.0% |
| Q2 26 | — | 30.1% | ||
| Q1 26 | — | 31.5% | ||
| Q4 25 | 20.5% | 14.3% | ||
| Q3 25 | 6.8% | 14.5% | ||
| Q2 25 | 1.5% | 15.2% | ||
| Q1 25 | 0.1% | 11.7% | ||
| Q4 24 | 13.4% | 14.3% | ||
| Q3 24 | 11.8% | 14.9% |
| Q2 26 | — | $1.61 | ||
| Q1 26 | — | $1.71 | ||
| Q4 25 | — | $1.71 | ||
| Q3 25 | $0.59 | $1.70 | ||
| Q2 25 | $0.23 | $1.74 | ||
| Q1 25 | $0.01 | $1.26 | ||
| Q4 24 | $1.31 | $1.61 | ||
| Q3 24 | $0.80 | $1.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $586.2M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $4.0B |
| Total Assets | $3.7B | $6.9B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $586.2M | ||
| Q1 26 | — | $580.0M | ||
| Q4 25 | $98.3M | $580.0M | ||
| Q3 25 | — | $593.8M | ||
| Q2 25 | — | $568.2M | ||
| Q1 25 | — | $594.1M | ||
| Q4 24 | $561.8M | $620.8M | ||
| Q3 24 | — | $633.2M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $560.0M | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $608.2M | $2.0B | ||
| Q3 24 | — | $2.1B |
| Q2 26 | — | $4.0B | ||
| Q1 26 | — | $4.0B | ||
| Q4 25 | $1.2B | $4.0B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $1.4B | $4.0B | ||
| Q1 25 | $1.4B | $3.9B | ||
| Q4 24 | $1.4B | $3.8B | ||
| Q3 24 | $1.3B | $3.8B |
| Q2 26 | — | $6.9B | ||
| Q1 26 | — | $6.9B | ||
| Q4 25 | $3.7B | $6.9B | ||
| Q3 25 | $3.3B | $7.0B | ||
| Q2 25 | $3.4B | $6.9B | ||
| Q1 25 | $3.8B | $6.8B | ||
| Q4 24 | $4.1B | $6.7B | ||
| Q3 24 | $3.4B | $7.0B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.45× | 0.45× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | 0.45× | 0.52× | ||
| Q3 24 | — | 0.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | — |
| Free Cash FlowOCF − Capex | $-77.1M | $86.0M |
| FCF MarginFCF / Revenue | -23.4% | 21.6% |
| Capex IntensityCapex / Revenue | 21.5% | 4.4% |
| Cash ConversionOCF / Net Profit | -0.09× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $654.3M |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-6.2M | $209.5M | ||
| Q3 25 | $233.9M | $203.5M | ||
| Q2 25 | $299.3M | $161.7M | ||
| Q1 25 | $-350.0M | $105.7M | ||
| Q4 24 | $268.8M | $172.6M | ||
| Q3 24 | $-2.1M | $205.3M |
| Q2 26 | — | $86.0M | ||
| Q1 26 | — | $189.8M | ||
| Q4 25 | $-77.1M | $189.8M | ||
| Q3 25 | $167.0M | $188.7M | ||
| Q2 25 | $250.5M | $146.9M | ||
| Q1 25 | $-396.6M | $91.4M | ||
| Q4 24 | $212.9M | $157.1M | ||
| Q3 24 | $-40.0M | $191.6M |
| Q2 26 | — | 21.6% | ||
| Q1 26 | — | 46.6% | ||
| Q4 25 | -23.4% | 21.1% | ||
| Q3 25 | 56.5% | 21.5% | ||
| Q2 25 | 46.8% | 17.0% | ||
| Q1 25 | -106.9% | 11.2% | ||
| Q4 24 | 63.1% | 18.2% | ||
| Q3 24 | -17.2% | 24.0% |
| Q2 26 | — | 4.4% | ||
| Q1 26 | — | 15.6% | ||
| Q4 25 | 21.5% | 2.2% | ||
| Q3 25 | 22.6% | 1.7% | ||
| Q2 25 | 9.1% | 1.7% | ||
| Q1 25 | 12.6% | 1.8% | ||
| Q4 24 | 16.6% | 1.8% | ||
| Q3 24 | 16.3% | 1.7% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -0.09× | 1.63× | ||
| Q3 25 | 11.61× | 1.59× | ||
| Q2 25 | 38.10× | 1.23× | ||
| Q1 25 | -1232.46× | 1.11× | ||
| Q4 24 | 5.96× | 1.40× | ||
| Q3 24 | -0.08× | 1.72× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
IEX
Segment breakdown not available.
